Finally, to demonstrate that ZBRK1/VHL/p300 complex is associated with VHL promoter in renal cancer cells, we performed a chromatin immunoprecipitation (ChIP) assay focusing on a 105 bp fragment around the ZBRK1 site (−2145/−2041). Here, EP300 is linked to renal carcinoma.